Study of acute toxicity of the drug GML-1
https://doi.org/ 10.24411/2587-7836-2018-10016.
Abstract
Resume. Relevance. The acute toxicity evaluation is the anecessary stage of preclinical research of the new original anxiolytic drug GML-1. The present investigation aim is study of the GML-1 acute toxicity. Methods. GML-1 was administered once orally and intraperitoneally to mice and rats in the maximum possible volumes for each of the administration methods and for each animal species, at the highest possible concentrations. Equivalent volume of 1 % starch solution was administered to animals of the control groups. Euthanasia and pathoanatomical dissection were performed 14 days after the drug administration. The animal intoxication periods with a detailed description of the observed clinical picture were registered. Results. The mean lethal doses were not identified because GML-1 did not cause death of animals at injection of the maximum allowable volumes and maximum allowable concentrations. The morphological view of the internal organs, detected during pathoanatomical dissection of all experimental animals, did not differ from that observed in control animals. Conclusion. It was determined that the drug GML-1 at oral and intraperitoneal injection concerns to low-toxic substances. According to classification Sidorov K.K. (1973) this drug may be related to 4th toxicity class.
Conflicts of Interest Disclosure:
The authors declares that there is no conflict of interest.
Article info:
Date submitted: 06.04.2020
All authors have read and approved the final manuscript.
Peer review info:
"Pharmacokinetics and Pharmacodynamics" thanks the anonymous reviewer(s) for their contribution to the peer review of this work.
Editorial comment:
In case of any discrepancies in a text or the differences in its layout between the pdf-version of an article and its html-version the priority is given to the pdf-version.
About the Authors
A. V. Sorokina
FSBI «Zakusov Institute of Pharmacology»
Russian Federation
S. V. Alekseeva
FSBI «Zakusov Institute of Pharmacology»
Russian Federation
I. A. Miroshkina
FSBI «Zakusov Institute of Pharmacology»
Russian Federation
A. V. Volkova
FSBI «Zakusov Institute of Pharmacology»
Russian Federation
A. D. Durnev
FSBI «Zakusov Institute of Pharmacology»
Russian Federation
References
1. Красовский Г.Н., Рахманин Ю.А., Егорова Н.А. Экстраполяция токсикологических данных с животных на человека. -М.: Медицина; 2009.
2. Беленький М.Б. Элементы количественной оценки фармакологического эффекта. - Л.: Медгиз; 1963.
3. Руководство по проведению доклинических исследований лекарственных средств. Ч. 1. Методические рекомендации по изучению общетоксического действия лекарственных средств. Изучение острой токсичности. - М.: Гриф и К; 2012. - С. 15-17.
4. Guide for the Care and Use of Laboratory Animals. National Academies Press (US). Washington (DC). 2011. DOI: 10.17226/12910
5. Правила доклинической оценки безопасности фармакологических средств. РД 64-126-91. - М.: МЗ России, ФК; 1992.
6. Руководство по экспериментальному (доклиническому) изучению новых фармакологических веществ. Методические указания по изучению общетоксического действия фармакологических веществ. - М.: Медицина; 2005. С.41-47.
7. Гацура В.В. Методы первичного фармакологического исследования биологически активных веществ. - М.: Медицина; 1974.
For citations:
Sorokina A.V.,
Alekseeva S.V.,
Miroshkina I.A.,
Volkova A.V.,
Durnev A.D.
Study of acute toxicity of the drug GML-1. Pharmacokinetics and Pharmacodynamics. 2018;(2):65-70.
(In Russ.)
https://doi.org/ 10.24411/2587-7836-2018-10016.
Views:
1032